FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD
The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act.
By Melissa Schiller
Jonathan Havens, co-chair of the Cannabis Law Practice and the Food and Beverage Practice at Saul Ewing, told Cannabis Business Times earlier this month, regarding the FDA’s warning to the delta-8 companies, that the warning letters serve to weed out bad actors in the cannabis and hemp industries.
“While this is not a good look for the industry, I do think that it will make the industry better in that it will shine a light on whose marketing practices are unsavory and whose are responsible,” he said. “I think there could be an upside here."